University of Kabianga > Essay > Idiopathic pulmonary fibrosis and stem cell therapy risk > 8 page(s) > Published by: Chelsea Kim 3 years ago

Idiopathic pulmonary fibrosis and stem cell therapy risk

My father is a 72-year-old who suffers from idiopathic pulmonary fibrosis (IPF). It’s a lung disease with no cure with a bleak prognosis resulting in death 3 to 5 years of diagnosis.  In April, this year, dad had an exacerbation after an attempt to treat with stem cell therapy. Stem cell therapy is not FDA-approved or monitored and there are some providers making a lot of cash off vulnerab ...[Show More]

Published: 3 years ago

Published By: Chelsea Kim

 University of Kabianga > Essay > Idiopathic pulmonary fibrosis and stem cell therapy risk  page(s) 

Document Preview


Document Preview
Only 1 page is available for preview. Some parts have been intentionally blurred Unlock Now

Unlock this Document

Purchase the document to unlock it.

This paper costs $ 4

Unlock Now

You may use credit points to purchase the paper. Register below to earn 25 credits. Register Here >>

Category: Essay
Published By: Chelsea Kim
Published On: 3 years ago
Number of pages: 8
Language: English

You may use credit points to purchase the paper. Register below to earn 25 credits. Register Here >>